Inflammation and insulin resistance

FEBS Letters

Volumn 582, Issue 1, 2008, Pages 97-105

  de Luca, Carl ^a   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Inflammation; Insulin resistance; Macrophage

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CYTOKINE; I KAPPA B BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BONE MARROW CELL; ENDOPLASMIC RETICULUM STRESS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGE; METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

HUMANS; INFLAMMATION; INSULIN RESISTANCE; SIGNAL TRANSDUCTION;

EID: 37549022688     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.057     Document Type: Short Survey

References (67)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Weiss R., et al. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350 (2004) 2362-2374
3. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8 (2005) 571-578
4. de Luca C., and Olefsky J.M. Stressed out about obesity and insulin resistance. Nat. Med. 12 (2006) 41-42 (discussion 42)
5. Yu C., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236
6. Pickersgill L., Litherland G.J., Greenberg A.S., Walker M., and Yeaman S.J. Key role for ceramides in mediating insulin resistance in human muscle cells. J. Biol. Chem (2007)
7. Lee J.S., et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J. Appl. Physiol. 100 (2006) 1467-1474
8. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85-96
9. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., and White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277 (2002) 1531-1537
10. Rui L., Yuan M., Frantz D., Shoelson S., and White M.F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
11. Imamura T., et al. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol. Cell Biol. 19 (1999) 6765-6774
12. Usui I., Imamura T., Huang J., Satoh H., and Olefsky J.M. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 278 (2003) 13765-13774
13. Baumann C.A., et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407 (2000) 202-207
14. Roytblat L., Rachinsky M., Fisher A., Greemberg L., Shapira Y., Douvdevani A., and Gelman S. Raised interleukin-6 levels in obese patients. Obes. Res. 8 (2000) 673-675
15. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., and Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-{alpha} system. J. Clin. Endocrinol. Metab. 87 (2002) 4602-4606
16. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor-alpha: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
17. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. PNAS 100 (2003) 7265-7270
18. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
19. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
20. Kim F., et al. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 989-994
21. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
22. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
23. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
24. Stephens J.M., Lee J., and Pilch P.F. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272 (1997) 971-976
25. Ruan H., Hacohen N., Golub T.R., Van Parijs L., and Lodish H.F. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51 (2002) 1319-1336
26. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333
27. Tuncman G., Hirosumi J., Solinas G., Chang L., Karin M., and Hotamisligil G.S. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 103 (2006) 10741-10746
28. Williamson R.T., and Lond M.D. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. Brit. Med. J. 1 (1901) 760-762
29. Yin M.J., Yamamoto Y., and Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396 (1998) 77-80
30. Kim J.K., et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108 (2001) 437-446
31. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., and Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 (2001) 1673-1677
32. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005) 183-190
33. Sugita H., Fujimoto M., Yasukawa T., Shimizu N., Sugita M., Yasuhara S., Martyn J.A., and Kaneki M. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J. Biol. Chem. 280 (2005) 14203-14211
34. Yasukawa T., Tokunaga E., Ota H., Sugita H., Martyn J.A., and Kaneki M. s-Nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J. Biol. Chem. 280 (2005) 7511-7518
35. Perreault M., and Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7 (2001) 1138-1143
36. Carvalho-Filho M.A., Ueno M., Carvalheira J.B., Velloso L.A., and Saad M.J. Targeted disruption of iNOS prevents LPS-induced s-nitrosylation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E476-E482
37. Carvalho-Filho M.A., et al. s-Nitrosylation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54 (2005) 959-967
38. Schottelius A.J., Mayo M.W., Sartor R.B., and Baldwin Jr. A.S. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274 (1999) 31868-31874
39. van Exel E., Gussekloo J., de Craen A.J., Frolich M., Bootsma-Van Der Wiel A., and Westendorp R.G. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study. Diabetes 51 (2002) 1088-1092
40. Kim H.J., et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53 (2004) 1060-1067
41. Lumeng C.N., Bodzin J.L., and Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117 (2007) 175-184
42. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy - review of a new approach. Pharmacol. Rev. 55 (2003) 241-269
43. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
44. Xu H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
45. Arkan M.C., et al. IKK-[beta] links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191
46. Kurihara T., and Bravo R. Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J. Biol. Chem. 271 (1996) 11603-11607
47. Weisberg S.P., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116 (2006) 115-124
48. Kamei N., et al. Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance. J. Biol. Chem. 281 (2006) 26602-26614
49. Kanda H., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116 (2006) 1494-1505
50. Inouye K.E., Shi H., Howard J.K., Daly C.H., Lord G.M., Rollins B.J., and Flier J.S. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes (2007)
51. Lumeng C.N., Deyoung S.M., Bodzin J.L., and Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56 (2007) 16-23
52. Odegaard J.I., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007)
53. Mantovani A., Sica A., and Locati M. Macrophage polarization comes of age. Immunity 23 (2005) 344-346
54. Lesniewski L.A., et al. Bone marrow-specific Cap gene deletion protects against high fat diet-induced insulin resistance. Nat. Med. 13 (2007) 455-462
55. Hevener A.L., et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117 (2007) 1658-1669
56. Solinas, G., Vilcu, C., Neels, J.G., Luo, J.-L., Naugler, W., Olefsky, J.M. and Karin, M. (2007) JNK in macrophages plays a key role in the development of obesity-induced insulin resistance, in: Proceedings of Keystone Symposium: Metabolic Syndrome and Cardiovascular Disease, Steamboat Springs, CO.
57. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
58. Lee J.Y., and Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol. Cell 21 (2006) 174-185
59. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., and Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006) 3015-3025
60. deLuca, C., Saberi, M., Schenk, S., Lu, J.-C., Castorena, C., Greenberg, A.W. and Olefsky, J.M. (2007) Myeloid-derived Toll-like receptor 4 (Tlr4) is required for high fat diet induced hepatic insulin resistance, in: Proceedings of Keystone Symposium: Metabolic Syndrome and Cardiovascular Disease, Steamboat Springs, CO.
61. Diehl A.M. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G1-G5
62. Ozcan U., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
63. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., and Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006) 1137-1140
64. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664-671
65. Laskin D.L., Weinberger B., and Laskin J.D. Functional heterogeneity in liver and lung macrophages. J. Leukoc. Biol. 70 (2001) 163-170
66. Bruun J.M., Helge J.W., Richelsen B., and Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E961-E967
67. Di Gregorio G.B., et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54 (2005) 2305-2313